NEW YORK (AVAFIN) -- Institutional trading of Dendreon shares yielded a bought/sold volume ratio of 3.29.
A total of 37 block trades crossed the tape, resulting in 593,379
shares on the buy side vs. 180,223 shares on the sell side. From a cash flow perspective,
this implies that there was a cash inflow of $3,790,545 and a cash outflow of $1,137,948.
The net cash flow for DNDN is $2,652,597, demonstrating that institutions may
have positive outlook on the stock.
View all Block Trading Activities
On the options front, a total of 19,391 contracts were traded. Specifically, 16,281
call and 3,110 put contracts were traded yielding a 0.19 put/call ratio.
Dendreon Corporation is a biotechnology company focused on the discovery, development and commercialization of novel therapeutics that improve cancer treatment options for patients.
Shares of Dendreon gained $0.13 (+2.11%) to $6.30. The last trading session witnessed a
low of $6.18 and high of $6.57 during the day. The current trading volume of 8M is greater
than average volume of 5M shares. DNDN is trading above the 50 day moving average
and higher than the 200 day moving average. The stock's 52 week low is $3.69 and 52 week high is $17.04. Performance indicators show that the stock has gained 43.16% within the last quarter.
View Best Performing Stocks
